Skip to content

Treatment of severe obstructive sleep apnea syndrome: evaluation of a therapy combining continuous positive airway pressure with an oral appliance: a pilot study

Treatment of severe obstructive sleep apnea syndrome: evaluation of a therapy combining continuous positive airway pressure with an oral appliance: a pilot study - Pilot OA-CPAP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34972
Enrollment
10
Registered
2010-03-30
Start date
2010-04-14
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'obstructive sleep apnea syndrome' and 'sleep apnea'

Interventions

A bibloc oral appliance (Thornton Adjustable Positioner, Airway Management Inc., Dallas, TX, USA) will be made for all patients and will be fitted at 70% of the patient*s maximum mandibular protrusi

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: severe OSAS (AHI >30) Age > 20 years.

Exclusion criteria

Exclusion criteria: Medical and psychological exclusion: 1. Morphologic abnormalities of the upper airway 2. Endocrine dysfunction 3. Reported or documented severe cardiac- or pulmonary co-morbidity 4. Psychiatric disorders Dental exclusion for Oral Appliance therapy

Design outcomes

Primary

MeasureTime frame
The feasibility for planning a main randomised controlled study to compare OA-CPAP with CPAP alone. Patient*s satisfaction to an OA-CPAP with a questionnaire.

Secondary

MeasureTime frame
An ambulant polysomnography will be assessed for the AHI (efficacy), arousals, sleep stages and oxyhemoglobin saturation. Compliance is operationalized by assessing the number of hours per night and the number of nights per week that the device is used (questionnaire). Side-effects, EDS (excessive daytime sleepiness ) and neurobehavioral outcomes will also be evaluated with a questionnaire.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)